print logo

Egypt’s SEDICO Pharmaceutical starts operations at new cancer drugs factory

The company self-funded 70 percent of the investment in the new factory with bank loans accounting for the remaining 30 percent.
22.03.23 | Source: Zawya

Egypt’s SEDICO Pharmaceutical started operations at its new one billion Egyptian pounds ($32 million) oncology drugs factory, located in Sixth of October City.

The factory, spread over an area of 1,250 square metres, will eventually produce about 70 oncology drugs to supply the domestic market and export to countries in the Middle East, Africa and Eastern Europe regions.

Chairman of the Board Ali Al-Ghamrawi told Zawya Projects that the factory is being implemented in two phases, with production of ampoules and injections slated for Phase 1 and tablets and capsules for Phase 2.

He said it will produce 10 million units/vials annually at full capacity.

“Sales of oncology drugs produced by the new factory are expected to reach EGP1.4 billion ($45 million) over the next three years. It will also contribute to providing some cancer medicines at prices 30 to 60 percent cheaper than imports.”

Al-Ghamrawi disclosed that the factory was designed and built by Italy’s CSV Life Science, which provides engineering, construction, validation and compliance services for the global pharmaceutical industry. In a LinkedIn post, CSV Life Science had confirmed the participation of its Egyptian representative INNOX Engineering in the project. The production equipment was supplied by another Italian company Steriline.